GeoVax Labs Inc reports results for the quarter ended in March - Earnings Summary

Geovax Labs

14/05/2024 22:22

* GeoVax Labs Inc  GOVX.OQ  reported a quarterly adjusted
loss of
$2.47​​ per share for the quarter ended in March, lower than the
same quarter last year, when the company reported EPS of
$-2.25.  The lone analyst forecast for the quarter was for a
loss of $5.56 per share. 
    * Reported revenue was zero​; analysts expected zero. 
    * GeoVax Labs Inc's reported EPS for the quarter was a loss
of
$2.47​.
    * GeoVax Labs Inc shares had fallen by 17.5% this
quarter and
lost 69.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 85.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for GeoVax Labs Inc
is $90.00 
This summary was machine generated from LSEG data May 14 at
09:21 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -5.56          -2.47          Beat
 Dec. 31 2023      -2.78          -13.60         Missed
 Sep. 30 2023      -3.60          -4.80          Missed
 Jun. 30 2023      -2.47          -3.30          Missed